(NYSE: TMO) Thermo Fisher Scientific's forecast annual revenue growth rate of 4.16% is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 5.91%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.25%.
Thermo Fisher Scientific's revenue in 2024 is $42,492,000,000.On average, 8 Wall Street analysts forecast TMO's revenue for 2024 to be $16,392,292,937,632, with the lowest TMO revenue forecast at $16,333,549,849,252, and the highest TMO revenue forecast at $16,496,252,614,768. On average, 8 Wall Street analysts forecast TMO's revenue for 2025 to be $17,531,615,006,961, with the lowest TMO revenue forecast at $17,267,999,042,283, and the highest TMO revenue forecast at $17,732,631,784,965.
In 2026, TMO is forecast to generate $18,878,504,106,397 in revenue, with the lowest revenue forecast at $18,768,033,493,939 and the highest revenue forecast at $18,994,505,788,375.